AXL and neoplasm: Genetic ablation of CBL-B or pharmacological inhibition of AXL using LDC1267 resulted in enhanced NK cell cytotoxicity, mainly by increased degranulation and the release of cytotoxic granules such as perforin and granzyme B, which are essential for the destruction of tumor cells.